| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sunitinib | macrophage colony-stimulating factor 1 receptor | small molecule | NA | drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.08 | approved,investigational | inhibitor |
| sunitinib | vascular endothelial growth factor receptor 1 | small molecule | NA | drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.26 | approved,investigational | inhibitor |
| sunitinib | receptor-type tyrosine-protein kinase flt3 | small molecule | NA | drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.45 | approved,investigational | inhibitor |
| sunitinib | vascular endothelial growth factor receptor 3 | small molecule | NA | drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.24 | approved,investigational | inhibitor |
| sunitinib | vascular endothelial growth factor receptor 2 | small molecule | Successful target | TTD , drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.31 | approved,investigational | inhibitor |
| sunitinib | mast/stem cell growth factor receptor kit | small molecule | NA | drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.77 | approved,investigational | inhibitor |
| sunitinib | platelet-derived growth factor receptor alpha | small molecule | NA | drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.55 | approved,investigational | inhibitor |
| sunitinib | platelet-derived growth factor receptor beta | small molecule | NA | drugbank , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Gastrointestinal Stromal Tumors[MeSHID:D046152] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of gastrointestinal tract[MeSHID:D005770] |
0.28 | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||